Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 5852.00 | 5810.50 | 1.0071 | 1.0204 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5942.00 | 5810.50 | 1.0226 | 1.0647 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5959.00 | 5810.50 | 1.0256 | 1.0731 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 3570.27 | 5944.00 | 5810.50 | 1.0230 | 1.0657 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5553.00 | 5810.50 | 0.9557 | 0.8751 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 5000.00 | 3570.27 | 4748.00 | 5810.50 | 0.8171 | 0.5004 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5937.00 | 5810.50 | 1.0218 | 1.0623 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 5000.00 | 3570.27 | 2667.00 | 5810.50 | 0.4590 | -0.3398 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 5000.00 | 3570.27 | 2776.00 | 5810.50 | 0.4778 | -0.3010 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5854.00 | 5810.50 | 1.0075 | 1.0213 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6094.00 | 5810.50 | 1.0488 | 1.1403 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4699.00 | 5810.50 | 0.8087 | 0.4784 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4444.00 | 5810.50 | 0.7648 | 0.3656 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5756.00 | 5810.50 | 0.9906 | 0.9734 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 45.00 | 138.25 | 0.3255 | -0.7094 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 156.25 | 92.36 | 152.00 | 138.25 | 1.0995 | 1.3540 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 82.00 | 138.25 | 0.5931 | -0.1850 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 156.25 | 92.36 | 116.00 | 138.25 | 0.8391 | 0.4793 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 156.25 | 92.36 | 109.00 | 138.25 | 0.7884 | 0.3293 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 462.00 | 138.25 | 3.3418 | 14.9043 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 156.25 | 92.36 | 114.00 | 138.25 | 0.8246 | 0.4358 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 92.36 | 80.00 | 138.25 | 0.5787 | -0.2188 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 136.00 | 138.25 | 0.9837 | 0.9444 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 156.25 | 92.36 | 165.00 | 138.25 | 1.1935 | 1.7105 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 219.00 | 138.25 | 1.5841 | 3.4092 |